Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EBIT Growth

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EBIT Growth(%) 72.7428.206.6673.35-0.16

What is the latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) is 72.74 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202572.74
Mar202428.20
Mar20236.66
Mar202273.35
Mar2017-0.16

How is EBIT Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years EBIT Growth % Change
Mar2025 72.74
157.94
Mar2024 28.2
323.42
Mar2023 6.66
-90.92
Mar2022 73.35
Positive
Mar2017 -0.16 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EBIT Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,468.3 Cr NA -6.4% -20.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,764.0 Cr 2% 6.1% 4.7% Stock Analytics
DIVIS LABORATORIES ₹170,489.0 Cr 0.1% -3.5% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,442.0 Cr -0.3% 3.8% 15.5% Stock Analytics
CIPLA ₹123,088.0 Cr 1.1% -1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,162.0 Cr 2% 4.8% 4.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) NA

-6.4%

-20.8%

SENSEX

0.9%

0.8%

7.1%


You may also like the below Video Courses